COVID-19 Infection
Conditions
Interventions
Ultrashort wave treatment group:Lung ultrashort wave therapy+conventional therapy
Control group:Conventional therapy
Sponsors
Affiliated Rehabilitation Hospital of Nanchang University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. The age is 18-80 years old; 2. According to the diagnostic criteria of China's Diagnosis and Treatment Plan for COVID-19 Infection (Tenth Edition on Trial), the patient was diagnosed as COVID-19 infection; 3. According to the clinical typing criteria of the China's Diagnosis and Treatment Plan for COVID-19 Infection (Tenth Edition on Trial), the patients were identified as moderate or severe patients; 4. Vital signs are stable; 5. The patient and his/her family members voluntarily informed and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients requiring intensive care or mechanical ventilation; 2. There are metal implants in the upper torso; 3. Abnormal sensation in chest or upper back skin; 4. People with cardiac pacemaker in the body; 5. Patients with body temperature>38.5 ?; 6. Pregnant or lactating women; 7. Patients with active hemorrhage, uncontrolled active tuberculosis and malignant tumor; 8. Other pathogens (such as tuberculosis and mycoplasma) are positive.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CT improvement;White blood cell count;Lymphocyte percentage and count;C-reactive protein;Calcitonin;Neutrophil percentage and count;Blood gas analysis;Interleukin 6;SIRS score;Lung function test;6 min walking test;Borg Dyspnea Score;Respiratory muscle function test;global rating of change scales; | — |
Secondary
| Measure | Time frame |
|---|---|
| General vital indicators and symptoms;drug use;Ultrashort wave related adverse events; | — |
Countries
China
Contacts
Public ContactFeng Zen
the Fourth Affiliated Hospital of Nanchang University
Outcome results
None listed